Syndax Pharmaceuticals, Inc. (SNDX)
19.98
-0.34
(-1.67%)
USD |
NASDAQ |
Dec 08, 16:00
20.00
+0.02
(+0.10%)
After-Hours: 20:00
Syndax Pharmaceuticals Shareholders Equity (Quarterly): 115.43M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 158.07M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Verastem, Inc. | -15.53M |
| Puma Biotechnology, Inc. | 115.27M |
| Krystal Biotech, Inc. | 1.138B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 551.79M |
| Total Liabilities (Quarterly) | 436.36M |
| Debt to Equity Ratio | 2.993 |
| Current Ratio | 4.64 |
| Net Debt Paydown Yield | -5.15% |